INSIGHTS ON PHARMACEUTICAL INSPECTION

• All Eyes On X-Ray Inspection For Big Box Retailers

  Major retailers are mandating x-ray inspection for their suppliers. Uncover why this technology is crucial, and its capabilities beyond contamination detection to encompass vital quality and integrity checks.

• ICP-MS And ICP-OES: Tools For Elemental Impurity Analysis

  Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.

• Understanding Injectable Drug Container Closure Systems

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• Why A Dynamic, Digital Defect Library Is Now A Regulatory Expectation

  Maintaining a dynamic, digital defect library is essential for modern sterile manufacturing. Learn how this approach helps ensure consistency in batch disposition and supports regulatory compliance.

• What Is The Position Of Regulatory Authorities On PUPSIT?

  5/2/2025

  PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.

• Managing Risk In The Most Complex Combination Device Format

  2/18/2026

  Autoinjectors add mechanical forces and interactions that change how container closure integrity must be evaluated. Learn why device complexity creates new risks and how testing strategies must adapt.

• A Closer Look At Inspection Systems In Tablet And Capsule Production

  8/29/2024

  Walk through the rigorous inspection process pharmaceutical products undergo to ensure safety and quality, from granulated ingredients to packaging.

• M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical Production

  8/15/2025

  Ensure the safety and quality of your tablets and capsules with a metal detector designed for stability and high sensitivity in pharmaceutical and nutraceutical production.

• Lessons From FDA 483s And Warning Letters: Cleanroom Compliance

  12/8/2025

  Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.